Cargando…

Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines

Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was able to release a payload after a delay of approxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Samson, Kerr D. G., Bolle, Eleonore C. L., Sarwat, Mariah, Dargaville, Tim R., Melchels, Ferry P. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004877/
https://www.ncbi.nlm.nih.gov/pubmed/33807062
http://dx.doi.org/10.3390/pharmaceutics13030434
_version_ 1783672004030758912
author Samson, Kerr D. G.
Bolle, Eleonore C. L.
Sarwat, Mariah
Dargaville, Tim R.
Melchels, Ferry P. W.
author_facet Samson, Kerr D. G.
Bolle, Eleonore C. L.
Sarwat, Mariah
Dargaville, Tim R.
Melchels, Ferry P. W.
author_sort Samson, Kerr D. G.
collection PubMed
description Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was able to release a payload after a delay of approximately 21 days, in a consistent and reproducible manner. The device was constructed out of a flexible poly(ε-caprolactone) photo-cured network fabricated into a hollow tubular shape, which expelled approximately 10% of its total payload within 2 days after bursting. Characterisation of the factors that control the delay of release demonstrated that it was advantageous to adjust material permeability and device wall thickness over manipulation of the osmogent concentration in order to maintain reproducibility in burst delay times. The photo-cured poly(ε-caprolactone) network was shown to be fully degradable in vitro, and there was no evidence of cytotoxicity after 11 days of direct contact with primary dermal fibroblasts. This study provides strong evidence to support further development of flexible biomaterials with the aim of continuing improvement of the device burst characteristics in order to provide the greatest chance of the devices succeeding with in vivo vaccine booster delivery.
format Online
Article
Text
id pubmed-8004877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80048772021-03-29 Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines Samson, Kerr D. G. Bolle, Eleonore C. L. Sarwat, Mariah Dargaville, Tim R. Melchels, Ferry P. W. Pharmaceutics Article Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was able to release a payload after a delay of approximately 21 days, in a consistent and reproducible manner. The device was constructed out of a flexible poly(ε-caprolactone) photo-cured network fabricated into a hollow tubular shape, which expelled approximately 10% of its total payload within 2 days after bursting. Characterisation of the factors that control the delay of release demonstrated that it was advantageous to adjust material permeability and device wall thickness over manipulation of the osmogent concentration in order to maintain reproducibility in burst delay times. The photo-cured poly(ε-caprolactone) network was shown to be fully degradable in vitro, and there was no evidence of cytotoxicity after 11 days of direct contact with primary dermal fibroblasts. This study provides strong evidence to support further development of flexible biomaterials with the aim of continuing improvement of the device burst characteristics in order to provide the greatest chance of the devices succeeding with in vivo vaccine booster delivery. MDPI 2021-03-23 /pmc/articles/PMC8004877/ /pubmed/33807062 http://dx.doi.org/10.3390/pharmaceutics13030434 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Samson, Kerr D. G.
Bolle, Eleonore C. L.
Sarwat, Mariah
Dargaville, Tim R.
Melchels, Ferry P. W.
Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
title Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
title_full Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
title_fullStr Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
title_full_unstemmed Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
title_short Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
title_sort elastic bioresorbable polymeric capsules for osmosis-driven delayed burst delivery of vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004877/
https://www.ncbi.nlm.nih.gov/pubmed/33807062
http://dx.doi.org/10.3390/pharmaceutics13030434
work_keys_str_mv AT samsonkerrdg elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines
AT bolleeleonorecl elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines
AT sarwatmariah elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines
AT dargavilletimr elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines
AT melchelsferrypw elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines